Gilles Avenard guest of “Innover et Investir dans la Santé” (Innovate and Invest in Health) conference

Gilles Avenard, Acticor Biotech CEO is invited to talk about the relationships between Business Angels and startups in the field of human health.

The “Innover et Investir dans la Santé” (Innovate and Invest in Health) conference is organized by Angels Santé, the leading Business Angels network in France, and the Public Bank for Investment (BPI), during the French Business Angels Week of 2014.

More information in French on Business Angels Sante.

Read next in 'Media Coverage'

• Novel antiplatelet could circumvent bleeding risk for stroke patients
• Experimental antiplatelet compound for acute stroke shows promise
• New drug to prevent clots clears safety hurdle
• New blood thinner may prevent stroke, without risk for bleeding
• Acticor's blood thinner cuts hemorrhage risk in human study, could offer hope for acute stroke